Effect of Florida's Prescription Drug Monitoring Program and pill mill laws on opioid prescribing and use

JAMA Internal Medicine

Volumn 175, Issue 10, 2015, Pages 1642-1649

  Rutkow, Lainie ^a   Chang, Hsien Yen ^a   Daubresse, Matthew ^a   Webster, Daniel W ^a   Stuart, Elizabeth A ^a   Alexander, G Caleb ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCODONE BITARTRATE; MORPHINE; OPIATE; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ARTICLE; COMPARATIVE STUDY; DRUG LEGISLATION; DRUG SURVEILLANCE PROGRAM; DRUG USE; HUMAN; MAJOR CLINICAL STUDY; PILL MILL LAW; PRESCRIPTION; PRESCRIPTION DRUG MONITORING PROGRAM; PRIORITY JOURNAL; TIME SERIES ANALYSIS; UNITED STATES; ADULT; CLINICAL PRACTICE; DRUG CONTROL; DRUG MISUSE; FEMALE; LEGISLATION AND JURISPRUDENCE; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRESCRIPTION DRUG DIVERSION; PREVENTION AND CONTROL; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS;

ADULT; ANALGESICS, OPIOID; DRUG AND NARCOTIC CONTROL; EFFICIENCY, ORGANIZATIONAL; FEMALE; FLORIDA; HUMANS; MALE; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; PRESCRIPTION DRUG DIVERSION; PRESCRIPTION DRUG MISUSE; PRESCRIPTION DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84943542725     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.3931     Document Type: Article

References (31)

1. Warner M, Chen LH, Makuc DM, Anderson RN, Miniño AM. Drug poisoning deaths in the United States, 1980-2008. Published December 2011. NCHS data brief 81. http://www.cdc.gov/nchs/data/databriefs/db81.pdf. Accessed June 25, 2015.
2. Substance Abuse and Mental Health Services Administration. Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: US Dept of Health and Human Services; 2014. NSDUH series H-48. HHS publication (SMA) 14-4863.
3. Dart RC, Surratt HL, Cicero TJ, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372(3):241-248.
4. Centers for Disease Control and Prevention (CDC). Drug overdose deaths: Florida, 2003-2009. MMWR Morb Mortal Wkly Rep. 2011;60(26): 869-872.
5. Drug Enforcement Administration. Florida doctors no longer among the top oxycodone purchasers in the United States. Published April 5, 2013. http://www.justice.gov/dea/divisions/mia/2013/mia040513.shtml. Accessed June 25, 2015.
6. Fla Stat §458.3265, 459.0137.
7. Florida Office of the Attorney General. Florida's prescription drug diversion and abuse roadmap, 2012-2015. http://myfloridalegal.com/webfiles.nsf/wf/kgrg-8t8l5k/$file/prescriptiondrugdiversionandabuseroadmap.pdf. Accessed June 5, 2015.
8. Fla Stat §893.055.
9. Florida Department of Health. 2012-2013 Prescription Drug Monitoring Program annual report. Published December 1, 2013. http://www.floridahealth.gov/%5C/statistics-and-data/e-forcse/news-reports/-documents/2012-2013pdmpannual-report.pdf. Accessed June 5, 2015.
10. Florida Department of Health. 2011-2012 Prescription Drug Monitoring Program annual report. Published December 1, 2012. http://www.floridahealth.gov/%5C/statistics-and-data/e-forcse/news-reports/-documents/2011-2012pdmp-annual-report.pdf. Accessed June 5, 2015.
11. Johnson H, Paulozzi L, Porucznik C, Mack K, Herter B; Hal Johnson Consulting and Division of Disease Control and Health Promotion, Florida Department of Health. Decline in drug overdose deaths after state policy changes: Florida, 2010-2012. MMWR Morb Mortal Wkly Rep. 2014;63 (26):569-574.
12. Delcher C, Wagenaar AC, Goldberger BA, Cook RL, Maldonado-Molina MM. Abrupt decline in oxycodone-caused mortality after implementation of Florida's Prescription Drug Monitoring Program. Drug Alcohol Depend. 2015;150:63-68.
13. Surratt HL, O'Grady C, Kurtz SP, et al. Reductions in prescription opioid diversion following recent legislative interventions in Florida. Pharmacoepidemiol Drug Saf. 2014;23(3):314-320.
14. Hwang CS, Turner LW, Kruszewski SP, Kolodny A, Alexander GC. Prescription drug abuse: a national survey of primary care physicians. JAMA Intern Med. 2015;175(2):302-304.
15. IMS Health. http://www.imshealth.com/portal/site/imshealth. Accessed June 25, 2015.
16. Ohio State Board of Pharmacy. Attention pharmacists: major change in the O.A.R.R.S. report to address the "M.E.D." Ohio Initiative. Published October 11, 2013. http://pharmacy.ohio.gov/Documents/Pubs/Special/OARRS/Changes %20Coming%20to%20OARRS%20for%20Opioid %20Guidelines%20-%2010.11.2013.pdf. Accessed June 25, 2015.
17. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152(2):85-92.
18. State Medical Board of Ohio. Guidelines for prescribing opioids for the treatment of chronic, non-terminal pain: 80mg of a morphine equivalent daily dose (MED) "trigger point." Published 2013. http://www.opioidprescribing.ohio.gov/PDF/OARRS/Print-Prescribing-Guidelinesfor%20.pdf. Accessed June 25, 2015.
19. Diggle PJ, Heagerty P, Liang KY, Zeger SL. Analysis of Longitudinal Data. New York, NY: Oxford University Press; 2012. Oxford statistical science series.
20. Finklea KM, Sacco LN, Bagalman E. Congressional Research Service. Washington, DC: Prescription Drug Monitoring Programs; 2013.
21. Centers for Disease Control and Prevention. Public Health Law Program: menu of pain management clinic regulation. Published 2014. http://www.cdc.gov/phlp/docs/menu-pmcr.pdf. Accessed June 27, 2015.
22. Brady JE, Wunsch H, DiMaggio C, Lang BH, Giglio J, Li G. Prescription drug monitoring and dispensing of prescription opioids. Public Health Rep. 2014;129(2):139-147.
23. Office of Diversion Control, Drug Enforcement Administration. Automation of Reports and Consolidated Orders System(ARCOS): Retail Summary Reports. Springfield, VA: US Dept of Justice; date unknown. http://www.deadiversion.usdoj.gov/arcos/. Accessed July 1, 2015.
24. Reisman RM, Shenoy PJ, Atherly AJ, Flowers CR. Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy. Subst Abuse. 2009;3:41-51.
25. Clark T, Eadie J, Kreiner P, Strickler G. Prescription drug monitoring programs: an assessment of the evidence for best practices. Published 2012. http://www.pdmpexcellence.org/sites/all/pdfs/Brandeis-PDMP-Report-final.pdf. Accessed June 26, 2015.
26. Haffajee RL, Jena AB, Weiner SG. Mandatory use of prescription drug monitoring programs. JAMA. 2015;313(9):891-892.
27. Volkow ND, McLellan TA, Cotto JH, Karithanom M, Weiss SR. Characteristics of opioid prescriptions in 2009. JAMA. 2011;305(13):1299-1301.
28. Dasgupta N, Creppage K, Austin A, Ringwalt C, Sanford C, Proescholdbell SK. Observed transition from opioid analgesic deaths toward heroin. Drug Alcohol Depend. 2014;145:238-241.
29. Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559-574.
30. Dasgupta N, Kramer ED, Zalman MA, et al. Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend. 2006;82 (2):135-142.
31. Alexander GC, Kruszewski SP, Webster DW. Rethinking opioid prescribing to protect patient safety and public health. JAMA. 2012;308(18): 1865-1866.